Arylamine N-acetyltransferase 1 deficiency inhibits drug-induced cell death in breast cancer cells: switch from cytochrome C-dependent apoptosis to necroptosis.
Courtney E. McAleese(The University of Queensland), Rodney F. Minchin(The University of Queensland)
Cited by 1
Related Papers
Effects of human arylamine <i>N</i>‐acetyltransferase I knockdown in triple‐negative breast cancer cell lines
|Cancer Medicine|2015|47
Arylamine N-Acetyltransferase 1 Regulates Expression of Matrix Metalloproteinase 9 in Breast Cancer Cells: Role of Hypoxia-Inducible Factor 1-α
|Molecular Pharmacology|2019|20
The MBNL/CELF Splicing Factors Regulate Cytosolic Sulfotransferase 4A1 Protein Expression during Cell Differentiation
|Drug Metabolism and Disposition|2019|9